Multiplex PCR-Based Neutralization (MPBN) Assay for Titers Determination of the Three Types of Anti-Poliovirus Neutralizing-Antibodies
- PMID: 32150852
- PMCID: PMC7157629
- DOI: 10.3390/vaccines8010120
Multiplex PCR-Based Neutralization (MPBN) Assay for Titers Determination of the Three Types of Anti-Poliovirus Neutralizing-Antibodies
Abstract
Determination of poliovirus-neutralizing antibodies is an important part of clinical studies of poliovirus vaccines, epidemiological surveillance and seroprevalence studies that are crucial for global polio eradication campaigns. The conventional neutralization test is based on inhibition of cytopathic effect caused by poliovirus by serial dilutions of test serum. It is laborious, time-consuming and not suitable for large scale analysis. To overcome these limitations, a multiplex PCR-based neutralization (MPBN) assay was developed to measure the neutralizing antibody titers of anti-poliovirus sera against three serotypes of the virus in the same reaction and in shorter time. All three anti-poliovirus sera types were analyzed in a single assay. The MPBN assay was reproducible, robust and sensitive. Its lower limits of titration for the three anti-poliovirus sera types were within range of 0.76-1.64 per mL. Different anti-poliovirus sera were tested with conventional and MPBN assays; the results obtained by both methods correlated well and generated similar results. The MPBN is the first neutralization assay that specifically titrates anti-poliovirus antibodies against the three serotypes of the virus in the same reaction; it can be completed in two to three days instead of ten days for the conventional assay and can be automated for high-throughput implementation.
Keywords: IPV; OPV; anti-poliovirus antibodies seroprevalence; clinical trials; immunogenicity; neutralization.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Multiplex PCR-based titration (MPBT) assay for determination of infectious titers of the three Sabin strains of live poliovirus vaccine.Virol J. 2019 Oct 28;16(1):122. doi: 10.1186/s12985-019-1233-6. Virol J. 2019. PMID: 31660997 Free PMC article.
-
Application of MPBT Assay for Multiplex Determination of Infectious Titers and for Selection of the Optimal Formulation for the Trivalent Novel Oral Poliovirus Vaccine.Viruses. 2024 Jun 14;16(6):961. doi: 10.3390/v16060961. Viruses. 2024. PMID: 38932253 Free PMC article.
-
A safe and reliable neutralization assay based on pseudovirus to measure neutralizing antibody titer against poliovirus.J Med Virol. 2017 Dec;89(12):2075-2083. doi: 10.1002/jmv.24909. Epub 2017 Aug 29. J Med Virol. 2017. PMID: 28786502
-
Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?Public Health Rev. 1993-1994;21(1-2):143-50. Public Health Rev. 1993. PMID: 8041881 Review.
-
ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccines.Expert Rev Vaccines. 2005 Apr;4(2):167-72. doi: 10.1586/14760584.4.2.167. Expert Rev Vaccines. 2005. PMID: 15889990 Review.
Cited by
-
Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World.Vaccines (Basel). 2020 Dec 24;9(1):9. doi: 10.3390/vaccines9010009. Vaccines (Basel). 2020. PMID: 33374343 Free PMC article.
References
-
- Laassri M., Lottenbach K., Belshe R., Rennels M., Plotkin S., Chumakov K. Analysis of Reversions in the 5′-Untranslated Region of Attenuated Poliovirus after Sequential Administration of Inactivated and Oral Poliovirus Vaccines. J. Infect. Dis. 2006;193:1344–1349. doi: 10.1086/503366. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources